CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology (CGON) reported Preferred Dividend Payments of -$12.4 million for Q4 2023, down 3133.17% quarter-over-quarter from $410000.0 in Q3 2023.

CG Oncology (CGON) Preferred Dividend Payments (2023) Analysis & Trends

CG Oncology has reported Preferred Dividend Payments for 1 years, with the latest figure at -$12.4 million in Q4 2023.

For the quarter ending Q4 2023, Preferred Dividend Payments changed N/A year-over-year to -$12.4 million; the trailing twelve-month figure through Dec 2024 stood at -$12.4 million (down 175.38% YoY), and the FY2023 full-year result was $410000.0, changed N/A from the prior year.
Preferred Dividend Payments for Q4 2023 stood at -$12.4 million, down from $410000.0 in the prior quarter.
The five-year high for Preferred Dividend Payments was $3.8 million in Q2 2023, with the low at -$12.4 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	CG Oncology	5.16 Bn	5.16 Bn	-1.88 Mn	-

Download Data